Translational elongation rate changes in encephalomyocarditis virus-infected and interferon-treated cells.
Infection of mouse L cells with encephalomyocarditis virus results in a rapid inhibition of host protein synthesis before the synthesis of viral proteins. Although no alterations in initiation factor activities have been demonstrated in encephalomyocarditis virus-infected mouse cells, a defect in polypeptide chain elongation has been shown to occur in infected cell extracts. We investigated the significance of this elongation defect in the host shutoff phenomenon in vivo. Average polypeptide chain elongation rates were measured at various times after infection. Interferon was used as a reagent to separate temporarily the virus-induced alterations. Encephalomyocarditis virus infection of L cells was shown to lead to a progressive reduction in the elongation rate. Whereas interferon pretreatment delayed the decrease in elongation rate in a dose-dependent manner, it failed to alter the kinetics of host shutoff, suggesting that slowing of elongation steps played no significant role in this phenomenon. In addition, interferon pretreatment of either mock-infected or virus-infected cells led to no elongation defect that could be attributed to interferon action.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004686:Encephalomyocarditis virus / Q000254:growth & development* / Q000378:metabolism; D007372:Interferons / Q000494:pharmacology*; D007700:Kinetics; D007739:L Cells; D051379:Mice; D010441:Peptide Chain Elongation, Translational; D011132:Polyribosomes / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D014176:Protein Biosynthesis; D014764:Viral Proteins / Q000096:biosynthesis
D014764:Viral Proteins; D007372:Interferons; D011188:Potassium